Antibiotic Prescribing in Connection to Childbirth: An Observational Study in Two Districts in Lao PDR
Abstract
:1. Introduction
2. Results
2.1. General Characteristics of the Study Subjects
2.2. Antibiotic Prescription Rate
2.3. Comparison of Antibiotic Prescription among Women with Different Delivery Modes
2.3.1. During Hospitalization
2.3.2. At Discharge
2.3.3. Antibiotic Prescription in Relation to Childbirth
2.4. Comparison of Antibiotic Prescriptions between District Hospitals and Health Centers
2.4.1. Uncomplicated Vaginal Delivery Group
2.4.2. Vaginal Delivery with Episiotomy or Perineal Tear Group
3. Discussion
Strengths and Limitations
4. Materials and Methods
4.1. Study Areas
4.2. Data Collection
4.3. Data Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Say, L.; Chou, D.; Gemmill, A.; Tuncalp, O.; Moller, A.B.; Daniels, J.; Gulmezoglu, A.M.; Temmerman, M.; Alkema, L. Global causes of maternal death: A WHO systematic analysis. Lancet Glob. Health 2014, 2, e323–e333. [Google Scholar] [CrossRef] [Green Version]
- Muller, A.E.; Oostvogel, P.M.; Steegers, E.A.; Dorr, P.J. Morbidity related to maternal group B streptococcal infections. Acta Obstet. Gynecol. Scand. 2006, 85, 1027–1037. [Google Scholar] [CrossRef] [PubMed]
- Tharpe, N. Postpregnancy genital tract and wound infections. J. Midwifery Women Health 2008, 53, 236–246. [Google Scholar] [CrossRef] [PubMed]
- Esteves Mills, J.; Flynn, E.; Cumming, O.; Dreibelbis, R. Determinants of clean birthing practices in low- and middle-income countries: A scoping review. BMC Public Health 2020, 20, 602. [Google Scholar] [CrossRef]
- WHO. WHO Recommendations for Prevention and Treatment of Maternal Peripartum Infections. Available online: https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/peripartum-infections-guidelines/en/ (accessed on 20 September 2021).
- WHO. WHO Recommendation on Prophylactic Antibiotics for Women Undergoing Caesarean Section. Available online: https://apps.who.int/iris/handle/10665/341865 (accessed on 25 September 2021).
- WHO. WHO Recommendation on Routine Antibiotic Prophylaxis for Women Undergoing Operative Vaginal Birth. Available online: https://apps.who.int/iris/handle/10665/341862 (accessed on 25 September 2021).
- Sulis, G.; Adam, P.; Nafade, V.; Gore, G.; Daniels, B.; Daftary, A.; Das, J.; Gandra, S.; Pai, M. Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis. PLoS Med. 2020, 17, e1003139. [Google Scholar] [CrossRef]
- Keohavong, B.; Sihavong, A.; Soukhaseum, T.; Oudomsak, P.; Souliyavong, K.; Soundavong, K.; Voradeth, S.; Kounnavong, S.; Houamboun, K.; Akkhavong, K.; et al. Use of antibiotics among mothers after normal delivery in two provinces in Lao PDR. In Proceedings of the Third International Conference on Improving Use of Medicines, Antalya, Turkey, 14–18 November 2011. [Google Scholar]
- Keohavong, B.; Syhakhang, L.; Sengaloundeth, S.; Nishimura, A.; Ito, K. Rational use of drugs: Prescribing and dispensing practices at public health facilities in Lao PDR. Pharmacoepidemiol. Drug Saf. 2006, 15, 344–347. [Google Scholar] [CrossRef]
- Keohavong, B.; Vonglokham, M.; Phoummalaysith, B.; Louangpradith, V.; Inthaphatha, S.; Kariya, T.; Saw, Y.M.; Yamamoto, E.; Hamajima, N. Antibiotic prescription for under-fives with common cold or upper respiratory tract infection in Savannakhet Province, Lao PDR. Trop. Med. Health 2019, 47, 16. [Google Scholar] [CrossRef] [Green Version]
- Quet, F.; Vlieghe, E.; Leyer, C.; Buisson, Y.; Newton, P.N.; Naphayvong, P.; Keoluangkhot, V.; Chomarat, M.; Longuet, C.; Steenkeste, N.; et al. Antibiotic prescription behaviours in Lao People’s Democratic Republic: A knowledge, attitude and practice survey. Bull. World Health Organ. 2015, 93, 219–227. [Google Scholar] [CrossRef]
- Sychareun, V.; Sihavong, A.; Machowska, A.; Onthongdee, X.; Chaleunvong, K.; Keohavong, B.; Eriksen, J.; Hanson, C.; Vongsouvath, M.; Marrone, G.; et al. Knowledge, Attitudes, Perception and Reported Practices of Healthcare Providers on Antibiotic Use and Resistance in Pregnancy, Childbirth and Children under Two in Lao PDR: A Mixed Methods Study. Antibiotics 2021, 10, 1462. [Google Scholar] [CrossRef]
- Clifford, V.; Daley, A. Antibiotic prophylaxis in obstetric and gynaecological procedures: A review. Aust. N. Z. J. Obstet. Gynaecol. 2012, 52, 412–419. [Google Scholar] [CrossRef]
- Committee on Practice, B.-O. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstet. Gynecol. 2018, 132, e103–e119. [Google Scholar] [CrossRef]
- Sharma, S.; Kumari, N.; Sengupta, R.; Malhotra, Y.; Bhartia, S. Rationalising antibiotic use after low-risk vaginal deliveries in a hospital setting in India. BMJ Open Qual. 2021, 10, e001413. [Google Scholar] [CrossRef]
- Berhan, Y.; Kirba, S.; Gebre, A. Still No Substantial Evidence to Use Prophylactic Antibiotic at Operative Vaginal Delivery: Systematic Review and Meta-Analysis. Obstet. Gynecol. Int. 2020, 2020, 1582653. [Google Scholar] [CrossRef]
- Jones, K.; Webb, S.; Manresa, M.; Hodgetts-Morton, V.; Morris, R.K. The incidence of wound infection and dehiscence following childbirth-related perineal trauma: A systematic review of the evidence. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019, 240, 1–8. [Google Scholar] [CrossRef]
- Gommesen, D.; Nohr, E.A.; Drue, H.C.; Qvist, N.; Rasch, V. Obstetric perineal tears: Risk factors, wound infection and dehiscence: A prospective cohort study. Arch. Gynecol. Obstet. 2019, 300, 67–77. [Google Scholar] [CrossRef]
- Liabsuetrakul, T.; Choobun, T.; Peeyananjarassri, K.; Islam, Q.M. Antibiotic prophylaxis for operative vaginal delivery. Cochrane Database Syst. Rev. 2020, 3, CD004455. [Google Scholar] [CrossRef] [Green Version]
- Buppasiri, P.; Lumbiganon, P.; Thinkhamrop, J.; Thinkhamrop, B. Antibiotic prophylaxis for third- and fourth-degree perineal tear during vaginal birth. Cochrane Database Syst. Rev. 2014, 10, CD005125. [Google Scholar] [CrossRef] [Green Version]
- Iyer, S.; Ablett, J.; Williams, L. Antibiotic Treatment & Prophylaxis Guideline for Obstetrics (GL787); NHS Foundation Trust Royal Berkshire: London, UK, 2021. [Google Scholar]
- Smaill, F.M.; Grivell, R.M. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. The Cochrane Database Syst. Rev. 2014, 10, CD007482. [Google Scholar] [CrossRef] [Green Version]
- Lao Statistics Bureau. Lao Social Indicator Survey II 2017; Survey Findings Report; Lao Statistics Bureau and UNICEF: Vientiane, Lao PDR, 2018. [Google Scholar]
- Lyimo, F.M.; Massinde, A.N.; Kidenya, B.R.; Konje, E.T.; Mshana, S.E. Single dose of gentamicin in combination with metronidazole versus multiple doses for prevention of post-caesarean infection at Bugando Medical Centre in Mwanza, Tanzania: A randomized, equivalence, controlled trial. BMC Pregnancy Childbirth 2013, 13, 123. [Google Scholar] [CrossRef] [Green Version]
- Mohammed, S.O.; SD, A.S.; Gaya, S.A.; Rabiu, A. The efficacy of two doses versus 7 days’ course of prophylactic antibiotics following cesarean section: An experience from Aminu Kano Teaching Hospital. Ann. Afr. Med. 2020, 19, 103–112. [Google Scholar] [CrossRef]
- Shakya, A.; Sharma, J. Comparison of single versus multiple doses of antibiotic prophylaxis in reducing post-elective Caesarean section infectious morbidity. Kathmandu Univ. Med. J. 2010, 8, 179–184. [Google Scholar] [CrossRef]
- Westen, E.H.; Kolk, P.R.; van Velzen, C.L.; Unkels, R.; Mmuni, N.S.; Hamisi, A.D.; Nakua, R.E.; Vlek, A.L.; van Beekhuizen, H.J. Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial. Acta Obstet. Gynecol. Scand. 2015, 94, 43–49. [Google Scholar] [CrossRef]
- Antibiotic prophylaxis in surgery: Summary of a Swedish-Norwegian Consensus Conference. Scand. J. Infect. Dis. 1998, 30, 547–557. [CrossRef]
- Sway, A.; Wanyoro, A.; Nthumba, P.; Aiken, A.; Ching, P.; Maruta, A.; Gunturu, R.; Solomkin, J. Prospective Cohort Study on Timing of Antimicrobial Prophylaxis for Post-Cesarean Surgical Site Infections. Surg. Infect. 2020, 21, 552–557. [Google Scholar] [CrossRef]
- Mackeen, A.D.; Packard, R.E.; Ota, E.; Berghella, V.; Baxter, J.K. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst. Rev. 2014, 12, CD009516. [Google Scholar] [CrossRef]
- Sharma, M.; Sanneving, L.; Mahadik, K.; Santacatterina, M.; Dhaneria, S.; Stalsby Lundborg, C. Antibiotic prescribing in women during and after delivery in a non-teaching, tertiary care hospital in Ujjain, India: A prospective cross-sectional study. J. Pharm. Policy Pract. 2013, 6, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Market Research Laos: Capture the Potential Economic Growth of Laos. Available online: https://www.marketresearchsoutheastasia.com/page/laos (accessed on 25 September 2021).
- WHO. Lao People’s Democratic Republic Key Indicators. Available online: https://apps.who.int/gho/data/node.goe.ki-LAO?lang=en (accessed on 25 September 2021).
- Machowska, A.; Sihavong, A.; Eriksen, J.; Vongsouvath, M.; Marrone, G.; Sychareun, V.; Hanson, C.; Keohavong, B.; Brauner, A.; Mayxay, M.; et al. Containment of Antibiotic REsistance-measures to improve antibiotic use in pregnancy, childbirth and young children (CAREChild): A protocol of a prospective, quasiexperimental interventional study in Lao PDR. BMJ Open 2020, 10, e040334. [Google Scholar] [CrossRef] [PubMed]
- REDCap. Research Electronic Data Capture. Available online: https://projectredcap.org/software/ (accessed on 28 September 2021).
- WHO. ATC Classification Index with DDDs. 2022. Available online: https://www.whocc.no/atc_ddd_index_and_guidelines/atc_ddd_index/ (accessed on 28 September 2021).
- Hutchinson, J.M.; Patrick, D.M.; Marra, F.; Ng, H.; Bowie, W.R.; Heule, L.; Muscat, M.; Monnet, D.L. Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada. Can. J. Infect. Dis. 2004, 15, 29–35. [Google Scholar] [CrossRef] [PubMed]
- WHO. Anatomical Therapeutic Chemical (ATC) Classification. Available online: https://www.who.int/tools/atc-ddd-toolkit/atc-classification (accessed on 20 March 2022).
- WHO Collaborating Center for Drug Statistics Methodology. DD—Definition and General Considerations. Available online: https://www.whocc.no/ddd/definition_and_general_considera/ (accessed on 20 March 2022).
Variable | Group | Total n (%) | Feuang n (%) | Vangvieng n (%) | p |
---|---|---|---|---|---|
Number | 1777 (100.0) | 682 (38.4) | 1095 (61.6) | ||
Age *a | <20 | 366 (21.2) | 151 (23.5) | 215 (19.9) | 0.12 |
20–30 | 1088 (63.2) | 402 (62.5) | 686 (63.5) | ||
>30 | 269 (15.6) | 90 (14.0) | 179 (16.6) | ||
Delivery | CS group | 69 (3.9) | - *c | 69 (6.5) | <0.01 |
Mode | UVD group | 875 (49.2) | 453 (66.4) | 422 (38.5) | |
VD + E/P group | 778 (43.8) | 221 (32.4) | 557 (50.7) | ||
VD + other complications *b | 55 (3.1) | 8 (1.2) | 47 (4.3) |
Groups | Feuang | Vangvieng | ||||
---|---|---|---|---|---|---|
Items | UVD n (%) | VD + E/P n (%) | CS n (%) | UVD n (%) | VD + E/P n (%) | |
During the hospitalization | ||||||
Days on antibiotics | ||||||
≤1 day | 448 (98.9) | 220 (99.5) | 3 (4.4) | 422 (100.0) | 551 (98.9) | |
2–4 days | 5 (1.1) | 1 (0.5) | 7 (10.1) | 0 (0.0) | 5 (0.9) | |
5 days | 0 (0.0) | 0 (0.0) | 59 (85.5) | 0 (0.0) | 1 (0.2) | |
Generic name of antibiotic | ||||||
amoxicillin | 66 (14.6) | 9 (4.1) | 0 (0.0) | 421 (99.8) | 10 (1.8) | |
ampicillin | 385 (85.0) | 211 (95.5) | 0 (0.0) | 0 (0.0) | 17 (3.1) | |
ampicillin + gentamicin | 0 (0.0) | 0 (0.0) | 68 (98.6) | 1 (0.2) | 529 (95.0) | |
Other *a | 2 (0.4) | 1 (0.4) | 1 (1.5) | 0 (0.0) | 1 (0.2) | |
Route of administration | ||||||
Oral | 413 (91.2) | 128 (57.9) | 0 (0.0) | 421 (99.8) | 10 (1.8) | |
Intramuscular | 37 (8.2) | 84 (38.0) | 1 (1.5) | 1 (0.2) | 452 (81.1) | |
Intravenous | 3 (0.7) | 9 (4.1) | 68 (98.6) | 0 (0.0) | 95 (17.1) | |
At discharge | ||||||
Days on antibiotics | ||||||
≤3 days | 2 (0.4) | 2 (0.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
4 days | 360 (79.5) | 121 (54.8) | 0 (0.0) | 422 (100.0) | 0 (0.0) | |
5 days | 91 (20.1) | 98 (44.3) | 69 (100.0) | 0 (0.0) | 557 (100.0) | |
Name of antibiotics | ||||||
amoxicillin | 70 (15.5) | 57 (25.8) | 68 (98.6) | 418 (99.1) | 553 (99.3) | |
ampicillin | 381 (84.1) | 164 (74.2) | 0 (0.0) | 4 (1.0) | 4 (0.7) | |
Other *b | 2 (0.4) | 0 (0.0) | 1 (1.5) | 0 (0.0) | 0 (0.0) | |
Antibiotics DDDs/woman | 8.18 (1.64) | 8.29 (1.38) | 17.54 (1.63) | 9.98 (0.25) | 10.98 (0.44) |
Groups | UVD Group | VD + E/P Group | |||||
---|---|---|---|---|---|---|---|
Items | District Hospitals n (%) | Health Centers n (%) | p | District Hospitalsn (%) | Health Centers n (%) | p | |
Number of women | 680 | 195 | 676 | 102 | |||
During the hospitalization | |||||||
Days on antibiotics | |||||||
≤1 day | 675 (99.3) | 195 (100.0) | 669 (99.0) | 102 (100.0) | |||
2–4 days | 5 (0.7) | 0 (0.0) | 6 (0.9) | 0 (0.0) | |||
5 days | 0 (0.0) | 0 (0.0) | 1 (0.1) | 0 (0.0) | |||
Generic name of antibiotic | ** | ** | |||||
amoxicillin | 422 (62.1) | 65 (33.3) | 10 (1.5) | 9 (8.8) | |||
ampicillin | 255 (37.5) | 130 (66.7) | 135 (20.0) | 93 (91.2) | |||
ampicillin + gentamicin | 1 (0.1) | 0 (0.0) | 529 (78.3) | 0 (0.0) | |||
Other *a | 2 (0.3) | 0 (0.0) | 2 (0.3) | 0 (0.0) | |||
Route of administration | ** | ||||||
Oral | 659 (96.9) | 175 (89.7) | 118 (17.5) | 20 (19.6) | |||
Intramuscular | 18 (2.6) | 20 (10.3) | 462 (68.3) | 74 (72.6) | |||
Intravenous | 3 (0.4) | 0 (0.0) | 96 (14.2) | 8 (7.8) | |||
At discharge | |||||||
Days on antibiotics | ** | * | |||||
≤3 days | 2 (0.3) | 0 (0.0) | 2 (0.3) | 0 (0.0) | |||
4 days | 677 (99.6) | 105 (53.9) | 114 (16.9) | 7 (6.9) | |||
5 days | 1 (0.1) | 90 (46.1) | 560 (82.8) | 95 (93.1) | |||
Name of antibiotics | ** | ** | |||||
amoxicillin | 419 (61.6) | 69 (35.4) | 553 (81.8) | 57 (55.9) | |||
ampicillin | 259 (38.1) | 126 (64.6) | 123 (18.2) | 45 (44.1) | |||
Other *b | 2 (0.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |||
Antibiotics DDDs/woman | 9.03 (1.30) | 9.10 (2.02) | 10.35 (1.43) | 9.31 (1.37) | ** |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yan, W.; Machowska, A.; Sihavong, A.; Sychareun, V.; Chaleunvong, K.; Keohavong, B.; Eriksen, J.; Hanson, C.; Vongsouvath, M.; Brauner, A.; et al. Antibiotic Prescribing in Connection to Childbirth: An Observational Study in Two Districts in Lao PDR. Antibiotics 2022, 11, 448. https://doi.org/10.3390/antibiotics11040448
Yan W, Machowska A, Sihavong A, Sychareun V, Chaleunvong K, Keohavong B, Eriksen J, Hanson C, Vongsouvath M, Brauner A, et al. Antibiotic Prescribing in Connection to Childbirth: An Observational Study in Two Districts in Lao PDR. Antibiotics. 2022; 11(4):448. https://doi.org/10.3390/antibiotics11040448
Chicago/Turabian StyleYan, Weirong, Anna Machowska, Amphoy Sihavong, Vanphanom Sychareun, Kongmany Chaleunvong, Bounxou Keohavong, Jaran Eriksen, Claudia Hanson, Manivanh Vongsouvath, Annelie Brauner, and et al. 2022. "Antibiotic Prescribing in Connection to Childbirth: An Observational Study in Two Districts in Lao PDR" Antibiotics 11, no. 4: 448. https://doi.org/10.3390/antibiotics11040448
APA StyleYan, W., Machowska, A., Sihavong, A., Sychareun, V., Chaleunvong, K., Keohavong, B., Eriksen, J., Hanson, C., Vongsouvath, M., Brauner, A., Mayxay, M., Kounnavong, S., & Stålsby Lundborg, C. (2022). Antibiotic Prescribing in Connection to Childbirth: An Observational Study in Two Districts in Lao PDR. Antibiotics, 11(4), 448. https://doi.org/10.3390/antibiotics11040448